Clearstead Advisors, LLC Viatris Inc Transaction History
Clearstead Advisors, LLC
- $6.3 Billion
- Q1 2025
A detailed history of Clearstead Advisors, LLC transactions in Viatris Inc stock. As of the latest transaction made, Clearstead Advisors, LLC holds 4,025 shares of VTRS stock, worth $34,574. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,025
Previous 3,560
13.06%
Holding current value
$34,574
Previous $44,000
20.45%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding VTRS
# of Institutions
1,136Shares Held
953MCall Options Held
4.15MPut Options Held
2.65M-
Vanguard Group Inc Valley Forge, PA145MShares$1.24 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$796 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD74.5MShares$640 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az64.9MShares$558 Million3.35% of portfolio
-
State Street Corp Boston, MA61.5MShares$528 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $10.4B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...